{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:25:17Z","timestamp":1792445117626,"version":"4.5.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer J."],"DOI":"10.1038\/s41408-024-01147-y","type":"journal-article","created":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T07:02:04Z","timestamp":1726815724000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Characterization of MYC Rearrangements in Multiple Myeloma: an Optical Genome Mapping Approach"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9296-5085","authenticated-orcid":false,"given":"Jung","family":"Yoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taesung","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Ah","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2302-3825","authenticated-orcid":false,"given":"Soo-Young","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,20]]},"reference":[{"key":"1147_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-00359-2","volume":"10","author":"SV Rajkumar","year":"2020","unstructured":"Rajkumar SV, Kumar S. Multiple myeloma current treatment algorithms. Blood Cancer J. 2020;10:94.","journal-title":"Blood Cancer J"},{"key":"1147_CR2","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1002\/ajh.26590","volume":"97","author":"SV Rajkumar","year":"2022","unstructured":"Rajkumar SV. Multiple myeloma: 2022 update on diagnosis, risk stratification, and management. Am J Hematol. 2022;97:1086\u2013107.","journal-title":"Am J Hematol"},{"key":"1147_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-022-00679-5","volume":"12","author":"P Hagen","year":"2022","unstructured":"Hagen P, Zhang J, Barton K. High-risk disease in newly diagnosed multiple myeloma: beyond the R-ISS and IMWG definitions. Blood Cancer J. 2022;12:83.","journal-title":"Blood Cancer J"},{"key":"1147_CR4","doi-asserted-by":"publisher","first-page":"6581","DOI":"10.1158\/1078-0432.CCR-20-2283","volume":"26","author":"N Abdallah","year":"2020","unstructured":"Abdallah N, Baughn LB, Rajkumar SV, Kapoor P, Gertz MA, Dispenzieri A, et al. Implications of MYC rearrangements in newly diagnosed multiple myeloma. Clin Cancer Res. 2020;26:6581\u20138.","journal-title":"Clin Cancer Res"},{"key":"1147_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2014.13","volume":"4","author":"BA Walker","year":"2014","unstructured":"Walker BA, Wardell CP, Brioli A, Boyle E, Kaiser MF, Begum DB, et al. Translocations at 8q24 juxtapose MYC with genes that harbor superenhancers resulting in overexpression and poor prognosis in myeloma patients. Blood Cancer J. 2014;4:e191.","journal-title":"Blood Cancer J"},{"key":"1147_CR6","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.3324\/haematol.2019.217927","volume":"105","author":"A Mikulasova","year":"2020","unstructured":"Mikulasova A, Ashby C, Tytarenko RG, Qu P, Rosenthal A, Dent JA, et al. Microhomology-mediated end joining drives complex rearrangements and overexpression of MYC and PVT1 in multiple myeloma. Haematologica. 2020;105:1055\u201366.","journal-title":"Haematologica"},{"key":"1147_CR7","doi-asserted-by":"publisher","first-page":"5430","DOI":"10.1158\/1078-0432.CCR-21-0005","volume":"27","author":"N Sharma","year":"2021","unstructured":"Sharma N, Smadbeck JB, Abdallah N, Zepeda-Mendoza C, Binder M, Pearce KE, et al. The prognostic role of MYC structural variants identified by NGS and FISH in multiple myeloma. Clin Cancer Res. 2021;27:5430\u20139.","journal-title":"Clin Cancer Res"},{"key":"1147_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09555-6","volume":"10","author":"BG Barwick","year":"2019","unstructured":"Barwick BG, Neri P, Bahlis NJ, Nooka AK, Dhodapkar MV, Jaye DL, et al. Multiple myeloma immunoglobulin lambda translocations portend poor prognosis. Nat Commun. 2019;10:1911.","journal-title":"Nat Commun"},{"key":"1147_CR9","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1080\/10428194.2016.1187275","volume":"57","author":"AG Szabo","year":"2016","unstructured":"Szabo AG, Gang AO, Pedersen M\u00d8, Poulsen TS, Klausen TW, N\u00f8rgaard P. Overexpression of c-myc is associated with adverse clinical features and worse overall survival in multiple myeloma. Leuk Lymphoma. 2016;57:2526\u201334.","journal-title":"Leuk Lymphoma"},{"key":"1147_CR10","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/ajh.26587","volume":"97","author":"AC Smith","year":"2022","unstructured":"Smith AC, Neveling K, Kanagal-Shamanna R. Optical genome mapping for structural variation analysis in hematologic malignancies. Am J Hematol. 2022;97:975\u201382.","journal-title":"Am J Hematol"},{"key":"1147_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-01059-x","volume":"14","author":"YS Zou","year":"2024","unstructured":"Zou YS, Klausner M, Ghabrial J, Stinnett V, Long P, Morsberger L, et al. A comprehensive approach to evaluate genetic abnormalities in multiple myeloma using optical genome mapping. Blood Cancer J. 2024;14:78.","journal-title":"Blood Cancer J"},{"key":"1147_CR12","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.ajhg.2021.06.001","volume":"108","author":"K Neveling","year":"2021","unstructured":"Neveling K, Mantere T, Vermeulen S, Oorsprong M, van Beek R, Kater-Baats E, et al. Next-generation cytogenetics: comprehensive assessment of 52 hematological malignancy genomes by optical genome mapping. Am J Hum Genet. 2021;108:1423\u201335.","journal-title":"Am J Hum Genet"},{"key":"1147_CR13","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s13000-014-0221-9","volume":"9","author":"N Fedchenko","year":"2014","unstructured":"Fedchenko N, Reifenrath J. Different approaches for interpretation and reporting of immunohistochemistry analysis results in the bone tissue - a review. Diagn Pathol. 2014;9:221.","journal-title":"Diagn Pathol"},{"key":"1147_CR14","doi-asserted-by":"publisher","first-page":"ra66","DOI":"10.1126\/scisignal.aad6275","volume":"9","author":"J K\u00fchn","year":"2016","unstructured":"K\u00fchn J, Wong LE, Pirkuliyeva S, Schulz K, Schwiegk C, F\u00fcnfgeld KG, et al. The adaptor protein CIN85 assembles intracellular signaling clusters for B cell activation. Sci Signal. 2016;9:ra66.","journal-title":"Sci Signal"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41408-024-01147-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-024-01147-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-024-01147-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T07:02:08Z","timestamp":1726815728000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41408-024-01147-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,20]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1147"],"URL":"https:\/\/doi.org\/10.1038\/s41408-024-01147-y","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,20]]},"assertion":[{"value":"10 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"165"}}